뒤로
Nykode Therapeutics AS(VACBF) 가격
VACBF 주가 차트
VACBF 재무
Nykode Therapeutics AS
$0.31
0%
$0
종가: Jan 27, 16:00:00 GMT-5
$0.31
0%
$0
애프터마켓: Jan 27, 20:00:00 GMT-5
수입
자산 및 부채 명세서
현금 흐름
연간
분기별
VACBF 소득
미화 수백만 달러. 회계 연도는 2월부터 1월까지입니다.
Follow-Up Questions
Nykode Therapeutics AS의 주요 재무제표는 무엇인가요?
VACBF의 주요 재무 비율은 무엇인가요?
Nykode Therapeutics AS의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Nykode Therapeutics AS은 수익성이 있나요?
Nykode Therapeutics AS에 부채가 있나요?
Nykode Therapeutics AS의 발행 주식은 몇 주인가요?
주요 통계
이전 종가
$0.31
시가
$0.31
일일 범위
$0.31 - $0.31
52주 범위
$0.1557 - $0.31
거래량
10.0K
평균 거래량
166
EPS(TTM)
-0.03
배당수익률
--
시가총액
$101.2M
NYKODE THERAPEUTICS ASA란 무엇인가요?
Nykode Therapeutics ASA is a clinical-stage biopharmaceutical company which engages in discovering and developing of novel immunotherapies. The company is headquartered in Oslo, Oslo and currently employs 62 full-time employees. The company went IPO on 2020-01-27. Nykode uses its vaccine technology platform to generate therapeutics in disease indications with unmet medical need. The firm develops next generation vaccines for clinical use, based on a deep understanding of immunological principles. Nykode Therapeutics’ main product candidates are VB10.16 and VB10.NEO. VB10.16 is a therapeutic cancer vaccine against HPV16-related cancers. VB10. NEO is a therapeutic cancer neoantigen vaccine. The firm also has two universal COVID-19 vaccine candidates in development.